Canada Biotechnology & Medical Research

Rakovina Therapeutics Inc (RKV)

Track

Track

Rakovina Therapeutics recorded one insider purchase totaling 10,000 CAD over the past ninety days. Director David Kideckel executed this acquisition on August 11, 2026. This activity occurs ahead of the upcoming August 27 results financiers, amidst a 30.4% stock price increase observed during the last quarter.
Ticker: RKV Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rakovina Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kideckel, David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
451.42
Quantity 50,729 -35.3%
Value CA$2,845,344
0.5
Meshcherekov, Yevgeniy Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
337.52
Quantity 53,618 +0.3%
Value CA$4,406,737
1.6
Prime Global Investment Fund Ltd. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
282.88
Quantity 98,185
Value CA$3,399,324
Kideckel, David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 200,000
Value CA$20,000
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 500,000 +24.3%
Value CA$50,000
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Sale
Price
0.06
Quantity 3,517,500
Value CA$193,462
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.06
Quantity 50,000 +2.5%
Value CA$2,750
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.07
Quantity 13,000 +0.4%
Value CA$910
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.17
Quantity 37,000 +1.1%
Value CA$6,401
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Sale
Price
0.19
Quantity 132,500 -3.7%
Value CA$25,175
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.06
Quantity 90,192 +4.8%
Value CA$5,412
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.08
Quantity 88,000 +2.5%
Value CA$6,600
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.08
Quantity 48,000 +1.4%
Value CA$3,600
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.08
Quantity 14,000 +0.4%
Value CA$1,050
1.6
Daugaard, Mads Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 25,000 +25.0%
Value CA$2,375
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 25,000 +1.4%
Value CA$2,375
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 7,143 +0.2%
Value CA$679
2.6
De Lucrezia, Alfredo Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 50,000 +1.5%
Value CA$5,000
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 100,000 +5.9%
Value CA$9,750
2.4
Bacha, Jeffrey Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 20,000 +1.2%
Value CA$2,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-11 B Purchase
Kideckel, David

Director of Issuer, Senior Officer of Issuer

Executive Director
50,729 -35.3%
451.42
CA$2,845,344 		50,729 -35.3% 451.42 CA$2,845,344
2025-09-11 2025-09-11 B Purchase
0.5
Meshcherekov, Yevgeniy

Director of Issuer

Non-Executive Director
53,618 +0.3%
337.52
CA$4,406,737 		53,618 +0.3% 337.52 CA$4,406,737
2026-07-28 2025-06-06 B Purchase
1.6
Prime Global Investment Fund Ltd.

10% Security Holder of Issuer

Large shareholder
98,185
282.88
CA$3,399,324 		98,185 282.88 CA$3,399,324
2025-06-10 2025-06-06 B Purchase
Kideckel, David

Director of Issuer, Senior Officer of Issuer

Executive Director
200,000
0.10
CA$20,000 		200,000 0.10 CA$20,000
2025-06-10 2025-06-06 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
500,000 +24.3%
0.10
CA$50,000 		500,000 +24.3% 0.10 CA$50,000
2025-05-29 2025-05-28 S Sale
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
3,517,500
0.06
CA$193,462 		3,517,500 0.06 CA$193,462
2025-04-14 2025-04-11 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
50,000 +2.5%
0.06
CA$2,750 		50,000 +2.5% 0.06 CA$2,750
2025-01-10 2025-01-08 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
13,000 +0.4%
0.07
CA$910 		13,000 +0.4% 0.07 CA$910
2025-01-08 2025-01-08 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
37,000 +1.1%
0.17
CA$6,401 		37,000 +1.1% 0.17 CA$6,401
2024-12-31 2024-12-31 S Sale
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
132,500 -3.7%
0.19
CA$25,175 		132,500 -3.7% 0.19 CA$25,175
2024-12-19 2024-12-13 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
90,192 +4.8%
0.06
CA$5,412 		90,192 +4.8% 0.06 CA$5,412
2024-10-28 2024-10-25 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
88,000 +2.5%
0.08
CA$6,600 		88,000 +2.5% 0.08 CA$6,600
2024-10-22 2024-10-21 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
48,000 +1.4%
0.08
CA$3,600 		48,000 +1.4% 0.08 CA$3,600
2024-10-22 2024-10-18 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
14,000 +0.4%
0.08
CA$1,050 		14,000 +0.4% 0.08 CA$1,050
2024-05-20 2024-05-16 B Purchase
1.6
Daugaard, Mads

Senior Officer of Issuer

Officer
25,000 +25.0%
0.10
CA$2,375 		25,000 +25.0% 0.10 CA$2,375
2024-04-22 2024-04-19 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
25,000 +1.4%
0.10
CA$2,375 		25,000 +1.4% 0.10 CA$2,375
2024-04-05 2024-04-05 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
7,143 +0.2%
0.10
CA$679 		7,143 +0.2% 0.10 CA$679
2024-04-05 2024-04-05 B Purchase
2.6
De Lucrezia, Alfredo

Director of Issuer, Senior Officer of Issuer

Executive Director
50,000 +1.5%
0.10
CA$5,000 		50,000 +1.5% 0.10 CA$5,000
2024-03-28 2024-03-28 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
100,000 +5.9%
0.10
CA$9,750 		100,000 +5.9% 0.10 CA$9,750
2023-12-12 2023-12-12 B Purchase
2.4
Bacha, Jeffrey

Senior Officer of Issuer

Officer
20,000 +1.2%
0.10
CA$2,000 		20,000 +1.2% 0.10 CA$2,000
Explore more

More insider trading research around Rakovina Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America